• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Alkanolamines

Recent Advances in the Study of 1-Amino-3-isopropoxy-propan-2-ol (CAS: 3141-83-1) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound 1-Amino-3-isopropoxy-propan-2-ol (CAS: 3141-83-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a building block in drug synthesis and its potential role in modulating biological pathways. This research briefing aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, synthetic utility, and emerging therapeutic applications.

Recent studies have demonstrated that 1-Amino-3-isopropoxy-propan-2-ol serves as a key intermediate in the synthesis of various bioactive molecules, including β-adrenergic receptor agonists and antiviral agents. Its unique structural features, characterized by the presence of both amino and isopropoxy functional groups, enable it to participate in diverse chemical reactions, making it a valuable scaffold for medicinal chemistry. A 2023 study published in the Journal of Medicinal Chemistry elucidated its role in the development of novel bronchodilators, showcasing its potential in treating respiratory disorders.

In addition to its synthetic utility, 1-Amino-3-isopropoxy-propan-2-ol has been investigated for its biological activity. Preliminary in vitro studies suggest that it may exhibit modest antimicrobial properties against certain Gram-positive bacteria, as reported in a recent issue of Bioorganic & Medicinal Chemistry Letters. Researchers are now exploring its mechanism of action, with particular interest in its interaction with bacterial cell membranes and potential synergies with existing antibiotics.

The pharmacokinetic profile of 1-Amino-3-isopropoxy-propan-2-ol has also been a subject of recent investigation. A 2024 preclinical study conducted by a European research consortium revealed favorable absorption and distribution characteristics in rodent models, with particularly good blood-brain barrier penetration. These findings open new possibilities for its use in central nervous system-targeted therapies, though further toxicological evaluation is required before clinical translation.

From a chemical production perspective, advancements have been made in the sustainable synthesis of 1-Amino-3-isopropoxy-propan-2-ol. A green chemistry approach published in ACS Sustainable Chemistry & Engineering demonstrated an enzymatic route to produce this compound with high enantioselectivity and reduced environmental impact compared to traditional methods. This development addresses growing concerns about the ecological footprint of pharmaceutical manufacturing while maintaining high purity standards required for medicinal applications.

Looking forward, the research community anticipates several promising directions for 1-Amino-3-isopropoxy-propan-2-ol. Computational chemistry studies are currently underway to model its interactions with various biological targets, which may reveal additional therapeutic applications. Furthermore, its potential as a chiral auxiliary in asymmetric synthesis continues to be explored, with recent successes in the preparation of optically active pharmaceutical intermediates. As these investigations progress, 1-Amino-3-isopropoxy-propan-2-ol is poised to maintain its relevance in both academic research and industrial drug development pipelines.

• 94616-61-2(1,4,7,10-Tetraoxacyclododecane-2-methanamine)
• 83585-56-2(2-Aminomethyl-15-crown-5)
• 83585-61-9(2-Aminomethyl-18-crown-6)
• 98279-42-6(2-Propanol, 1-amino-3-[2-amino-1-(aminomethyl)ethoxy]-)
• 114012-79-2(1-amino-3-(2-hydroxyethoxy)propan-2-ol)
• 88277-83-2(1,4-Dioxan-2-ylmethanamine)
• 35152-18-2(1-Amino-3-ethoxypropan-2-ol)
• 214190-74-6(1-Amino-3-(3-aminopropoxy)propan-2-OL)
• 91420-37-0(1,4,7,10-TETRAOXACYCLODODECANE-2-METHANAMINE, HYDROCHLORIDE)
• 4454-09-5(2-PROPANOL, 1,1'-[1,2-ETHANEDIYLBIS(OXY)]BIS[3-AMINO-)